Piper Sandler Maintains Neutral on Gilead Sciences, Raises Price Target to $73

Piper Sandler analyst Do Kim maintains Gilead Sciences (NASDAQ:GILD) with a Neutral and raises the price target from $72 to $73.

byBenzinga Newsdesk

April 29, 2022

1 minute read

Piper Sandler analyst Do Kim maintains Gilead Sciences (NASDAQ:GILD) with a Neutral and raises the price target from $72 to $73.

Evolus Q3 EPS $(0.35) Misses $(0.27) Estimate, Sales $26.68M Beat $25.53M Estimate

By Benzinga Newsdesk

November 2, 8:24 AM

Evolus (NASDAQ:EOLS) reported quarterly losses of $(0.35) per share which missed the analyst consensus estimate of $(0.27) by 29.63 percent. This is a 2.94 percent decrease over losses of $(0.34) per share from the same

EOLS

Deutsche Bank Maintains Hold on SpartanNash, Raises Price Target to $26

By Benzinga Newsdesk

June 3, 7:56 AM

Deutsche Bank analyst Krisztina Katai maintains SpartanNash (NASDAQ:SPTN) with a Hold and raises the price target from $25 to $26.

SPTN

Samsung’s Unpacked Event 2021: 2 New Smartphones, Improved Earbuds, A Feature-Rich Smartwatch

By Shanthi Rexaline

August 11, 3:07 PM

South Korean electronics giant Samsung Tuesday announced at its annual hardware unveiling event four new products that promise a superior user experience and come armed with advanced technology and features.

AAPL